ELCC Updates in Immunotherapy and Beyond for Non–Small Cell Lung Cancer - Episode 2
The panel discusses how patients with advanced NSCLC are sub-grouped in NSCLC and how to approach treatment for each group.
Sponsored in part by Regeneron. Content independently created by OncLive.